株式会社ヘリオス
AcquiredHealios develops treatments for retinal diseases and age-related macular degeneration (AMD) using cell technology.
What it does
"Healios is a pioneering medtech company dedicated to expanding treatment options for patients worldwide through regenerative medicine. With a mission to deliver new therapies and hope to patients globally, Healios focuses on two main areas of regenerative medicine: iPSC regenerative medicine and somatic stem cell regenerative medicine. Their iPSC regenerative medicine includes universal donor cells, cancer immunotherapy (NK cells), age-related macular degeneration, and liver diseases. On the other hand, somatic stem cell regenerative medicine targets conditions such as stroke and acute respiratory distress syndrome (ARDS). Healios is committed to developing innovative treatments in these fields to enhance patient health and quality of life."
Next to it in Healthcare and bio · Regenerative medicine for retinal disease
- Rege NephroPlug and Play
Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
- HepatxY Combinator S18
Replacing organ transplant with an infusion
- 株式会社セルージョンPlug and Play
Cellusion is a developer of corneal endothelial regenerative medicine intended to improve world visibility.
- 株式会社マトリクソームPlug and Play
Matricome develops regenerative medicines by disseminating laminin E8 fragment technology.
- Cell Factor Inc.Plug and Play
Renewal medicine 3 elements +1 authentic society implementation -from postcolona, from intractable diseases to pre -empty medical care. / 再生医療3要素 +1の本格社会実装 ～ポストコロナ、難病から先制医療まで～
- iHeart JapanPlug and Play
iHeart Japan is developing regenerative medicinal products for severe heart failure, using iPSC technologies.
- 株式会社メトセラPlug and Play
Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.
- マイキャン・テクノロジーズ株式会社Plug and Play
MiCAN Technologies medical and nursing Care company.